The statements of the pair of scientists, Uwoor Shahin and Ezlem Turetzi, who founded BioNTech "What the coronavirus vaccine taught us"
The hope for the use of a vaccine against cancer by 2030 is opened up by statements from the team at the pharmaceutical company Pfizer/BioNTech.
The pair of scientists, Uwoor Shahin and Ezlem Turetzi, who founded the pharmaceutical company in 2008, have been reluctant to say that a cure for cancer has been found, but admit that achievements have been made on which they will work.
They stressed that the manufacture and success of the vaccine to treat Covid-19, which has been widely distributed around the world, is helping to advance work on cancer.
The pair have worked on cancer immunotherapies tailored to individual patients.
The use of mRNA technology was achieved during the pandemic.
While conventional vaccines are produced with attenuated forms of the virus, mRNAs use only the genetic code of the virus.
An mRNA vaccine is injected into the body, where antigens are created that are then recognized by the immune system, preparing it to fight the disease.
Asked when patients could have access to cancer vaccines, Professor Shahin said this could happen "before 2030."
For her part, Professor Turetzi told the BBC the following: "What we have developed over decades for the cancer vaccine has helped develop the Covid-19 vaccine."
"We have seen in a large number of people how the immune system reacts to mRNA," the professor concluded."
Source: Cyprus Times
Contents of this article including associated images are belongs to Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source